Obamacare Subsidies Lapsed. Here's Why Health Insurer Stocks Are Watching the New Congress.

As the political landscape in the United States evolves, with Democrats poised to regain control in both the Senate and the House of Representatives, the implications for various sectors may become increasingly significant. One area that may witness a resurgence is the health insurance industry, particularly as Democrats advocate for reinstating subsidies for the individual health insurance market.

Recent events have seen health insurers operating within the Affordable Care Act (ACA) marketplace face considerable member churn. This trend was driven by escalating healthcare costs and the discontinuation of extended subsidies for lower-income individuals that were initially introduced during the pandemic. Consequently, millions of people who had previously maintained coverage found themselves without it, prompting a reevaluation of the industry's future.

However, there is a glimmer of hope on the horizon. Some Democrats are advocating for the restoration of these subsidies, which could potentially aid in bringing back the 3 million-plus individuals who withdrew from coverage. By doing so, insurers specializing in the ACA marketplace, such as Oscar Health (OSCR) and Centene (CNC), could experience a revitalization of membership.

These companies have previously endured considerable member churn, and the prospect of reinstating subsidies could bolster their insurance premiums.

While government-funded subsidies could be a contentious topic in political arenas, their potential implementation would undoubtedly prove advantageous for these providers, as higher insurance premiums would result. It is worth noting that healthcare inflation has historically been a boon for health insurance stocks, as long as companies price their coverage appropriately to generate profits.

For instance, Oscar Health, despite experiencing high member churn in 2026, anticipates record premiums this year, reaching an estimated $19 billion to $19.3 billion. Additionally, premiums are projected to increase further in the following year.

Over the past few weeks, health insurance stocks have demonstrated an upward trend as the likelihood of Democrats gaining control of Congress has grown. Although the prospects for subsidy restoration remain uncertain, as President Donald Trump retains the power to veto legislation, these stocks may still fare well in the long run.

Nonetheless, investors should be cognizant of potential risks, such as discussions surrounding the possibility of a nationalized health insurance system. This scenario could threaten the competitiveness of private insurers by introducing federal-level premiums, reminiscent of the student loan market's downfall two decades ago.

Despite these challenges, health insurance stocks like Oscar Health currently appear to be reasonably priced, considering their potential for sustained growth amidst healthcare inflation over the long term. For those who believe in this continued trend, Oscar Health's shares, as well as other insurance stocks, may represent a promising investment opportunity.